Loading ...

Defining Immune Tolerance in ANCA-associated Vasculitis (AAV)

(

AVATARS

)

ITN Protocol #:

ITN051AI

Branded Name:

AVATARS

ClinicalTrials.Gov ID:

NCT01934504

Treatment Protocol #:

Therapeutic Area:

Autoimmune Disease

Current Status:

Terminated

Summary:

Defining Immune Tolerance in ANCA-associated Vasculitis (AAV)

Clinical Operations Manager

ITN Biologist

ITN Biostat

NIAID Project Manager

Rho Data Manager

Rho Scientist

Study Personnel:

Protocol Chair

Alan Salama, MD PhDa.salama@ucl.ac.uk

Work: 

44 207 794 0500 x 36007

Protocol Chair

Patti Tostaptosta@immunetolerance.org

Work: 

415-353-4421

Protocol Chair

Kristina Harris, PhD

Work: 

Protocol Chair

Noha Lim, PhDnlim@immunetolerance.org

Work: 

240-235-6151

Protocol Chair

Susan Boohersusan.booher@nih.gov

Work: 

240-627-3481

Protocol Chair

Reginald Williamsreginald_williams@rhoworld.com

Work: 

919-595-6318

Protocol Chair

James Rochon, PhDjames_rochon@rhoworld.com

Work: 

919-595-6857